The 3rd China Clinical Trials Outsourcing Congress will focus on how to meet the challenges of conducting clinical trials in China and assessing the challenges and advantages of partnering with regional CROs versus setting up operations in China. The programme will focus on issues such as regulatory procedures, patient recruitment and retention, logistics and data management through case studies and keynote presentations from industry experts all actively involved in conducting clinical studies in China.

Topics and speakers on the agenda will include:

• An overview of the current clinical trials landscape in China - James Garner, Vice President and General Manager, Takeda Global Research and Development Centre, Singapore


• Major issues with conducting clinical trials in China - Stephen Porter, CEO VDDI Pharmaceuticals and Chief Scientific Officer, Dragon BioConsulting


• Clinical trial data collection and management in China - Julia Zhang, Associate Director, Biomedical Data Sciences and Informatics, Genzyme USA

For the full programme please visit: www.clinical-trials-events.com

Confirmed attendees already include VPs, Directors, Heads and Managers of Clinical Development, Outsourcing, Patient Recruitment, Clinical Supply Chain and Operations.

This congress will be co-located with the 1st Asia Clinical Trials Outsourcing Congress.

There are opportunities to exhibit in the centralised exhibition area, sponsor or have one-to-one prearranged meetings. Post conference workshops on topics of your choice are also available.

For further details please contact Steve Hambrook, Conference Director, on +44 (0) 7949 400917 or by email: steve@globalengage.co.uk

For pricing and package options, please contact Steve Hambrook, Conference Director, on +44 (0) 7949 400917 or by email: steve@globalengage.co.uk